OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antiproliferative Activity, Multikinase Inhibition, Apoptosis- Inducing Effects and Molecular Docking of Novel Isatin–Purine Hybrids
Ashwag S. Alanazi, Tebyan O. Mirgany, Aisha A. Alsfouk, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 610-610
Open Access | Times Cited: 12
Ashwag S. Alanazi, Tebyan O. Mirgany, Aisha A. Alsfouk, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 610-610
Open Access | Times Cited: 12
Showing 12 citing articles:
Synthesis, cytotoxicity, apoptosis-inducing activity and molecular docking studies of novel isatin–podophyllotoxin hybrids
Nguyễn Hà Thành, Ket Tran Van, Hai Pham‐The, et al.
RSC Advances (2025) Vol. 15, Iss. 4, pp. 2825-2839
Open Access
Nguyễn Hà Thành, Ket Tran Van, Hai Pham‐The, et al.
RSC Advances (2025) Vol. 15, Iss. 4, pp. 2825-2839
Open Access
Exploring the potential of isatin hybrids as anticancer agents: recent advances and future prospective
Parveen Gahlyan, Tushar Chauhan, Priyanka Jhajharia, et al.
Medicinal Chemistry Research (2025)
Closed Access
Parveen Gahlyan, Tushar Chauhan, Priyanka Jhajharia, et al.
Medicinal Chemistry Research (2025)
Closed Access
Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity
Abdulaziz A. Alotaibi, Hanadi H. Asiri, A. F. M. Motiur Rahman, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 5, pp. 101712-101712
Open Access | Times Cited: 13
Abdulaziz A. Alotaibi, Hanadi H. Asiri, A. F. M. Motiur Rahman, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 5, pp. 101712-101712
Open Access | Times Cited: 13
Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
Ashwag S. Alanazi, Tebyan O. Mirgany, Nawaf A. Alsaif, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 989-997
Open Access | Times Cited: 10
Ashwag S. Alanazi, Tebyan O. Mirgany, Nawaf A. Alsaif, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 989-997
Open Access | Times Cited: 10
Novel 7-Deazapurine Incorporating Isatin Hybrid Compounds as Protein Kinase Inhibitors: Design, Synthesis, In Silico Studies, and Antiproliferative Evaluation
Mohammed M. Alanazi, Ashwag S. Alanazi
Molecules (2023) Vol. 28, Iss. 15, pp. 5869-5869
Open Access | Times Cited: 7
Mohammed M. Alanazi, Ashwag S. Alanazi
Molecules (2023) Vol. 28, Iss. 15, pp. 5869-5869
Open Access | Times Cited: 7
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 7
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 7
Discovery of New Pyrrolo[2,3-d]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers
Abdulaziz A. Alotaibi, Mohammed M. Alanazi, A. F. M. Motiur Rahman
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1324-1324
Open Access | Times Cited: 6
Abdulaziz A. Alotaibi, Mohammed M. Alanazi, A. F. M. Motiur Rahman
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1324-1324
Open Access | Times Cited: 6
Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2: Promising candidates for anticancer therapy
Tebyan O. Mirgany, A. F. M. Motiur Rahman, Mohammed M. Alanazi
Journal of Molecular Structure (2024) Vol. 1309, pp. 138177-138177
Closed Access | Times Cited: 1
Tebyan O. Mirgany, A. F. M. Motiur Rahman, Mohammed M. Alanazi
Journal of Molecular Structure (2024) Vol. 1309, pp. 138177-138177
Closed Access | Times Cited: 1
Discovery of 1H-benzo[d]imidazole-(halogenated)Benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors
Tebyan O. Mirgany, Hanadi H. Asiri, A. F. M. Motiur Rahman, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 839-839
Open Access | Times Cited: 1
Tebyan O. Mirgany, Hanadi H. Asiri, A. F. M. Motiur Rahman, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 839-839
Open Access | Times Cited: 1
X-ray Crystal Structure, Hirshfeld Surface Analysis, DFT, and Anticancer Effect of 3-Hydroxy-4-phenyl-1,5-benzodiazepin-2-one Derivatives
Sanae Lahmidi, Ahmed H. Bakheit, El Mokhtar Essassi, et al.
Crystals (2023) Vol. 13, Iss. 12, pp. 1693-1693
Open Access | Times Cited: 4
Sanae Lahmidi, Ahmed H. Bakheit, El Mokhtar Essassi, et al.
Crystals (2023) Vol. 13, Iss. 12, pp. 1693-1693
Open Access | Times Cited: 4
The design, synthesis, biological evaluation, and molecular docking of new 5‐aminosalicylamide‐4‐thiazolinone hybrids as anticancer agents
Shimaa A. Othman, Ola F. Abou‐Ghadir, Wafaa S. Ramadan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 10
Closed Access | Times Cited: 3
Shimaa A. Othman, Ola F. Abou‐Ghadir, Wafaa S. Ramadan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 10
Closed Access | Times Cited: 3
Combining lavendustin C and 5-arylidenethiazolin-4-one-based pharmacophores toward multitarget anticancer hybrids
Shimaa A. Othman, Ola F. Abou‐Ghadir, Varsha Menon, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107884-107884
Closed Access
Shimaa A. Othman, Ola F. Abou‐Ghadir, Varsha Menon, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107884-107884
Closed Access
